These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28367604)

  • 1. Ultra-High Field Proton MR Spectroscopy in Early-Stage Amyotrophic Lateral Sclerosis.
    Cheong I; Marjańska M; Deelchand DK; Eberly LE; Walk D; Öz G
    Neurochem Res; 2017 Jun; 42(6):1833-1844. PubMed ID: 28367604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.
    Cheong I; Deelchand DK; Eberly LE; Marjańska M; Manousakis G; Guliani G; Walk D; Öz G
    J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):294-301. PubMed ID: 30467209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy.
    Weerasekera A; Peeters R; Sima D; Dresselaers T; Sunaert S; De Vocht J; Claeys K; Van Huffel S; Van Damme P; Himmelreich U
    Brain Res; 2019 Sep; 1718():22-31. PubMed ID: 31002818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated imaging of [
    Ratai EM; Alshikho MJ; Zürcher NR; Loggia ML; Cebulla CL; Cernasov P; Reynolds B; Fish J; Seth R; Babu S; Paganoni S; Hooker JM; Atassi N
    Neuroimage Clin; 2018; 20():357-364. PubMed ID: 30112276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis.
    Atassi N; Xu M; Triantafyllou C; Keil B; Lawson R; Cernasov P; Ratti E; Long CJ; Paganoni S; Murphy A; Salibi N; Seethamraju R; Rosen B; Ratai EM
    PLoS One; 2017; 12(5):e0177680. PubMed ID: 28498852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis.
    Han J; Ma L
    J Magn Reson Imaging; 2010 Feb; 31(2):305-8. PubMed ID: 20099342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy.
    Foerster BR; Pomper MG; Callaghan BC; Petrou M; Edden RA; Mohamed MA; Welsh RC; Carlos RC; Barker PB; Feldman EL
    JAMA Neurol; 2013 Aug; 70(8):1009-16. PubMed ID: 23797905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study.
    Ta D; Ishaque A; Srivastava O; Hanstock C; Seres P; Eurich DT; Luk C; Briemberg H; Frayne R; Genge AL; Graham SJ; Korngut L; Zinman L; Kalra S
    Neurology; 2021 Aug; 97(8):e803-e813. PubMed ID: 34426551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional Myo-Inositol, Creatine, and Choline Levels Are Higher at Older Age and Scale Negatively with Visuospatial Working Memory: A Cross-Sectional Proton MR Spectroscopy Study at 7 Tesla on Normal Cognitive Ageing.
    Lind A; Boraxbekk CJ; Petersen ET; Paulson OB; Siebner HR; Marsman A
    J Neurosci; 2020 Oct; 40(42):8149-8159. PubMed ID: 32994337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements.
    Block W; Karitzky J; Träber F; Pohl C; Keller E; Mundegar RR; Lamerichs R; Rink H; Ries F; Schild HH; Jerusalem F
    Arch Neurol; 1998 Jul; 55(7):931-6. PubMed ID: 9678310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.
    Sivák S; Bittšanský M; Kurča E; Turčanová-Koprušáková M; Grofik M; Nosál' V; Poláček H; Dobrota D
    Neuroradiology; 2010 Dec; 52(12):1079-85. PubMed ID: 20369234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique.
    Weiduschat N; Mao X; Hupf J; Armstrong N; Kang G; Lange DJ; Mitsumoto H; Shungu DC
    Neurosci Lett; 2014 Jun; 570():102-7. PubMed ID: 24769125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis.
    Sako W; Abe T; Izumi Y; Harada M; Kaji R
    J Clin Neurosci; 2016 May; 27():110-3. PubMed ID: 26765768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between cervical cord 1H-magnetic resonance spectroscopy and clinoco-electromyographic profile in amyotrophic lateral sclerosis.
    Ikeda K; Murata K; Kawase Y; Kawabe K; Kano O; Yoshii Y; Takazawa T; Hirayama T; Iwasaki Y
    Muscle Nerve; 2013 Jan; 47(1):61-7. PubMed ID: 23042532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR spectroscopy and imaging-derived measurements in the supplementary motor area for biomarkers of amyotrophic lateral sclerosis.
    Sako W; Izumi Y; Abe T; Haji S; Murakami N; Osaki Y; Matsumoto Y; Harada M; Kaji R
    Neurol Sci; 2021 Oct; 42(10):4257-4263. PubMed ID: 33594539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis.
    Liu C; Jiang R; Yi X; Zhu W; Bu B
    J Neurol Sci; 2015 Jan; 348(1-2):206-10. PubMed ID: 25524526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proton MR spectroscopy studies of the brain in ALS patients].
    Bak MI; Domzał-Stryga A; Królicki L; Kwieciński H
    Neurol Neurochir Pol; 2001; 35(1 Suppl):61-70. PubMed ID: 11732281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy.
    Gredal O; Rosenbaum S; Topp S; Karlsborg M; Strange P; Werdelin L
    Neurology; 1997 Apr; 48(4):878-81. PubMed ID: 9109871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients.
    Pohl C; Block W; Träber F; Schmidt S; Pels H; Grothe C; Schild HH; Klockgether T
    J Neurol Sci; 2001 Sep; 190(1-2):21-7. PubMed ID: 11574102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting neuronal dysfunction of hand motor cortex in ALS: A MRSI study.
    Wang Y; Li X; Chen W; Wang Z; Xu Y; Luo J; Lin H; Sun G
    Somatosens Mot Res; 2017 Mar; 34(1):15-20. PubMed ID: 28114839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.